Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert Vogelstein

Showing results (101-110 of 333) with videos related to

Pageof 34
Sort By:
Molecular Cancer Therapeutics|June 16, 2005
Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cellsKurtis E Bachman, Jason Sager, Ian Cheong, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulationKajsa Ericson, Christine Gan, Ian Cheong, et al.
The New England Journal of Medicine|February 1, 2002
Detection of APC mutations in fecal DNA from patients with colorectal tumorsGiovanni Traverso, Anthony Shuber, Bernard Levin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membraneDiana Mandelker, Sandra B Gabelli, Oleg Schmidt-Kittler, et al.
Cancer Research|February 12, 2004
TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI)Akash Nanda, Eleanor B Carson-Walter, Steven Seaman, et al.
Nature Communications|February 1, 2017
Reconstructing metastatic seeding patterns of human cancersJohannes G Reiter, Alvin P Makohon-Moore, Jeffrey M Gerold, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2016
Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencingMargaret L Hoang, Isaac Kinde, Cristian Tomasetti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolomeZachary J Reitman, Genglin Jin, Edward D Karoly, et al.
The Biochemical Journal|April 17, 2012
Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysisZhaohua Zheng, Syazwani I Amran, Jiuxiang Zhu, et al.
Science (New York, N.Y.)|December 15, 2007
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutationsChuan-Hsiang Huang, Diana Mandelker, Oleg Schmidt-Kittler, et al.
Pageof 34

Showing results (101-110 of 333) with videos related to

Sort By:
Pageof 34
Molecular Cancer Therapeutics|June 16, 2005
Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cellsKurtis E Bachman, Jason Sager, Ian Cheong, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulationKajsa Ericson, Christine Gan, Ian Cheong, et al.
The New England Journal of Medicine|February 1, 2002
Detection of APC mutations in fecal DNA from patients with colorectal tumorsGiovanni Traverso, Anthony Shuber, Bernard Levin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membraneDiana Mandelker, Sandra B Gabelli, Oleg Schmidt-Kittler, et al.
Cancer Research|February 12, 2004
TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI)Akash Nanda, Eleanor B Carson-Walter, Steven Seaman, et al.
Nature Communications|February 1, 2017
Reconstructing metastatic seeding patterns of human cancersJohannes G Reiter, Alvin P Makohon-Moore, Jeffrey M Gerold, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2016
Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencingMargaret L Hoang, Isaac Kinde, Cristian Tomasetti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolomeZachary J Reitman, Genglin Jin, Edward D Karoly, et al.
The Biochemical Journal|April 17, 2012
Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysisZhaohua Zheng, Syazwani I Amran, Jiuxiang Zhu, et al.
Science (New York, N.Y.)|December 15, 2007
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutationsChuan-Hsiang Huang, Diana Mandelker, Oleg Schmidt-Kittler, et al.
Pageof 34